Yonsei University Severance Hospital
Welcome,         Profile    Billing    Logout  
 212 Trials 
422 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rha, Sun Young
HERIZON-GEA-01, NCT05152147 / 2021-000296-36: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Recruiting
3
918
Europe, Canada, Japan, RoW
Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil
Jazz Pharmaceuticals, BeiGene, Ltd.
Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma
05/25
05/26
INTEGRATEIIb, NCT04879368 / 2020-004617-12: RegoNivo vs Standard of Care Chemotherapy in AGOC

Active, not recruiting
3
450
Europe, Japan, US, RoW
Regorafenib, Stivarga, Nivolumab, Opdivo, Docetaxel, Taxotere, Paclitaxel, Abraxane, Irinotecan, Camptosar, Trifluridine/Tipracil, Lonsurf
Australasian Gastro-Intestinal Trials Group, Bayer, Bristol-Myers Squibb, University of Sydney, Academic and Community Cancer Research United, Taiwanese Cooperative Oncology Group, Frankfurter Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, National Cancer Center Hospital East, Syneos Health
Gastro-Oesophageal Cancer
06/25
06/26
eNRGy, NCT02912949 / 2014-003277-42: A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion

Active, not recruiting
2
250
Europe, Canada, Japan, US, RoW
zenocutuzumab (MCLA-128), bispecific, MCLA-128
Merus N.V.
Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
12/26
12/26
NCT05512182: Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression

Withdrawn
2
50
RoW
Chemotherapy
Yonsei University
Recurrent/Advanced Gastric Cancer
10/23
10/23
NCT05270889: Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial

Not yet recruiting
2
50
RoW
Tislelizumab+Zanidatamab
Yonsei University
HER2-positive Gastric Cancer
06/24
06/24
ZWI-ZW25-201, NCT03929666: A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Active, not recruiting
2
74
Canada, US, RoW
ZW25 (Zanidatamab), Capecitabine, Cisplatin, Fluorouracil, Leucovorin, Oxaliplatin, Bevacizumab, Gemcitabine
Jazz Pharmaceuticals
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
07/25
07/25
HER-RAM, NCT04888663: Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer ( Study)

Active, not recruiting
1/2
50
RoW
Trastuzumab + Ramucirumab + Paclitaxel
Yonsei University
Recurrent/Metastatic Gastric Cancer
09/21
09/21
NCT05400915: Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients

Completed
1/2
27
RoW
Variltinib, Paclitaxel
Yonsei University
Gastric Cancer
12/21
06/22
NCT05529667: Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy.

Completed
1/2
15
RoW
INCB054828, Paclitaxel
Yonsei University
Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration Gastric Cancer, INCB054828, Paclitaxel
08/23
08/23
NCT04592211: Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Recruiting
1/2
71
RoW
olaparib+pembrolizumab+paclitaxel
Yonsei University
Gastric Cancer Stage IV
12/24
05/25
YH32367-101, NCT05523947: Clinical Trial of YH32367 in Patients with HER2 Positive Locally Advanced or Metastatic Solid Tumor

Recruiting
1/2
137
RoW
YH32367
Yuhan Corporation
HER2-Positive Solid Tumor
10/26
12/26
NCT04835896: Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer

Completed
1/2
49
RoW
M7824+paclitaxel
Yonsei University
Recurrent/Metastatic Gastric Cancer
10/23
10/23
NCT05894824: T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Recruiting
1/2
58
RoW
T-Dxd(Trastuzmab deruxtecan), Ramucirumab, Enhertu, Cyramza
Yonsei University
Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer
05/25
01/26
NCT05508737: Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer

Active, not recruiting
1/2
75
RoW
Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®), Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
Yonsei University
Gastric and Gastroesophageal Junction Adenocarcinoma
05/25
12/25
NCT03821233: A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Completed
1
112
Canada, US, RoW
ZW49
Zymeworks BC Inc.
HER2-expressing Cancers
09/24
10/24
KEYNOTE-C16, NCT04374877: Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Recruiting
1
260
US, RoW
CHS-388, Casdozokitug, Pembrolizumab, Keytruda®, Toripalimab, Loqtorzi®
Coherus Biosciences, Inc., Merck Sharp & Dohme LLC
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Non-small Cell Lung Cancer
12/25
08/26
NCT05159440: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

Active, not recruiting
1
70
US, RoW
TORL-2-307-MAB
TORL Biotherapeutics, LLC, Translational Research in Oncology
Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer, Gastroesophageal Junction Adenocarcinoma
12/24
12/25
NCT05156866: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Recruiting
1
70
US, RoW
TORL-2-307-ADC
TORL Biotherapeutics, LLC, Translational Research in Oncology
Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer, Gastroesophageal Junction Adenocarcinoma
01/25
01/26
NCT02951091: Biomarker-Integrated Umbrella, Advanced Gastric Cancer

Completed
N/A
400
RoW
biomarker screening
Yonsei University
Gastric Cancer
12/21
03/24
Zolbetuximab, NCT06767449: Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer

Recruiting
N/A
80
RoW
Yonsei University
Advanced Gastric Cancer
12/26
12/26
Lee, Sang Il
NCT05199441: Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia

Completed
4
226
RoW
Dihydroxydibutylether group, Galeo® group, Control group placebo, Placebo
Pusan National University Yangsan Hospital
Dyspepsia
07/23
07/23
NCT05701540: A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

Recruiting
4
338
RoW
Tegoprazan, Esomeprazole
HK inno.N Corporation
Gastroesophageal Reflux Disease
12/24
12/24
OPTIMIZE-APT, NCT05418556: Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Recruiting
4
3944
RoW
aspirin, clopidogrel, prasugrel, ticagrelor
Asan Medical Center
Coronary Artery Disease
08/27
12/28
NCT05051332: Phase 3 Clinical Trial of CartiLife® in Korea

Active, not recruiting
3
104
RoW
Autologous Chondrocyte Implantation (CartiLife®), CartiLife, Microfracture Surgery
Biosolution Co., Ltd.
Articular Cartilage Defect, Articular Cartilage Degeneration
09/23
09/24
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting
3
404
Europe, Canada, Japan, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo
Chinook Therapeutics, Inc.
IgA Nephropathy, Immunoglobulin A Nephropathy
12/26
12/26
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Recruiting
3
429
RoW
Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp®
Genexine, Inc., PT Kalbe Genexine Biologics
Anemia of Chronic Kidney Disease
12/26
09/27
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Hourglass Jul 2024 - Dec 2024 : Regulatory decision in Japan for COPD
Completed
3
806
Europe, Canada, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD DEVELOPMENT, LP
Pulmonary Disease, Chronic Obstructive
08/24
08/24
TETON-2, NCT05255991 / 2021-005881-17: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Active, not recruiting
3
597
Europe, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
07/25
07/25
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Active, not recruiting
3
3000
Europe, Japan, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
Obesity, Overweight, Overweight or Obesity
07/25
07/27
TRIUMPH-1, NCT05929066: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Active, not recruiting
3
2300
Europe, Canada, US, RoW
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Obesity, Overweight, Osteoarthritis, Knee, Obstructive Sleep Apnea
04/26
05/26
NCT04969731: Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Recruiting
3
408
RoW
Immuncell-LC, Autologous activated T lymphocyte, Gemcitabine
GC Cell Corporation
Pancreatic Ductal Adenocarcinoma
12/26
06/27
NCT06073132: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

Recruiting
2/3
80
Europe, US, RoW
AC-203, Vehicle
TWi Biotechnology, Inc.
Generalized Epidermolysis Bullosa Simplex
08/25
03/26
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
07/26
BBT877-IPF-004, NCT05483907: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients with IPF

Hourglass Jul 2023 - Dec 2023 : Interim data for the treatment of IPF
Checkmark Initiation of trial in idiopathic pulmonary fibrosis
Nov 2022 - Nov 2022: Initiation of trial in idiopathic pulmonary fibrosis
Active, not recruiting
2
129
Europe, US, RoW
BBT-877, Placebo
Bridge Biotherapeutics, Inc.
Idiopathic Pulmonary Fibrosis
01/25
09/25
NCT05944627: Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis

Not yet recruiting
1/2
68
NA
FURESTEM-OA Kit Inj., Placebo
Kang Stem Biotech Co., Ltd.
Knee Osteoarthritis
03/24
02/26
NCT05045534: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects

Completed
1
96
RoW
Comparison of TB-840 treatment with Placebo, TB-840
Therasid Bioscience
Healthy Volunteers
08/22
12/22
NCT02601417: The Necessity of Bile Cultures in Patients With Acute Cholangitis

Active, not recruiting
N/A
440
RoW
Ignoring result of bile culture
Seoul National University Hospital
Acute Cholangitis
03/24
07/24
NCT04810312: Combined Exercise and Nutrition Intervention for Spinal Sarcopenia

Not yet recruiting
N/A
35
NA
Combined exercise and nutrition intervention
Seoul National University Hospital
Sarcopenia
03/22
05/22
NCT04416763: Diagnostic Value of Endoscopic Ultrasound Elastography and Contrast Enhanced Endoscopic Ultrasound for Differential Diagnosis of Gallbladder Polyp

Recruiting
N/A
30
RoW
Seoul National University Hospital
Gallbladder Polyps or Masses Greater Than 8-10 mm in Size
04/22
06/22
NCT04750044: Refeeding in Post-ERCP Pancreatitis

Recruiting
N/A
80
RoW
early refeeding, delayed refeeding
Yonsei University
Post-ERCP Pancreatitis
11/22
12/22
DENEX HTN-KORAS, NCT04307836: DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications

Recruiting
N/A
140
RoW
Renal Denervation
Kalos Medical
Hypertension, Vascular Diseases, Cardiovascular Diseases
07/23
04/24
NCT05220475: A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent

Recruiting
N/A
108
RoW
fully covered self-expandable metal stent with an anchoring external plastic stent, uncovered self-expandable metal stent
Seoul National University Hospital
Malignant Biliary Obstruction
10/23
10/24
NCT05544825: Ice Plant (Mesembryanthemum Crystallinum) Extract in Patients With Impaired Fasting Glucose

Completed
N/A
40
RoW
Ice plant group, Placebo group
Pusan National University Yangsan Hospital
Impaired Fasting Glucose
10/23
10/23
NCT06628791: BK329 and Body Fat Reduction

Enrolling by invitation
N/A
100
RoW
BK329, Placebo
Pusan National University Yangsan Hospital
Obesity and Overweight
12/24
12/24
NCT03775837: Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

Recruiting
N/A
60
RoW
Panax Ginseng C.A. Mey Extract group, Placebo group
Pusan National University Yangsan Hospital
Liver Diseases
12/24
12/24
NCT04320199: Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Recruiting
N/A
30
RoW
Fermented Protaetia brevitarsis seulensis powder group, Placebo group
Pusan National University Yangsan Hospital
Alcoholic Liver Disease
12/24
12/24
NCT06091033: Perceived Stress and Black Rice (Oryza Sativa L.) Extract Fermented With Lactobacillus

Completed
N/A
80
RoW
Fermented rice, placebo
Pusan National University Yangsan Hospital
Perceived Stress
12/23
12/23
NCT05180136: Efficacy of Rice Bran Extract in Mildly to Moderately Depressed Adults

Completed
N/A
100
RoW
Rice bran extract group, Control group
Pusan National University Yangsan Hospital
Depression
12/22
12/22
NCT05548842: The Combined Seed Extracts of Cassia Obtusifolia Linne and Foeniculum Vulgare Mill in Patients With Chronic Constipation

Completed
N/A
100
RoW
The combined seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill, Placebo group
Pusan National University Yangsan Hospital
Chronic Constipation
12/23
12/23
NCT05729867: Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC

Recruiting
N/A
50
RoW
Endoscpic biliary drainage using fully covered metal stent
Seoul National University Hospital
Malignant Biliary Obstruction, Hepatocellular Carcinoma
04/24
04/25
NCT06120348: Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery

Recruiting
N/A
178
RoW
Charge-Balanced, Symmetric Nerve Stimulation, Sham Stimulation
Nu Eyne Co., Ltd.
Dry Eye Disease
04/24
08/24
NCT06427083: Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

Recruiting
N/A
240
RoW
Envlo Tablet, Envolomet SR Tablet
Daewoong Pharmaceutical Co. LTD.
Type 2 Diabetes Mellitus
12/25
06/26
NCT06419816: Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus

Recruiting
N/A
480
RoW
Physician-managed "WellCheck" use, self-managed "WellCheck" use
Daewoong Pharmaceutical Co. LTD.
Type 2 Diabetes
12/25
06/26
NCT06628804: Artemisia and Green Tea Extracts for Gastric Mucosal Health

Enrolling by invitation
N/A
100
RoW
Artemisia and green tea extracts, Placebo
Pusan National University Yangsan Hospital
Functional Dysphonia
12/25
12/25
NCT06629805: β-glucan and Exercise on Musculoskeletal Function in Sarcopenic Adults

Enrolling by invitation
N/A
116
RoW
Aureobasidium pullulans produced β-glucan, Placebo
Pusan National University Yangsan Hospital
Sarcopenia
12/25
12/25
NCT05493904: PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)

Recruiting
N/A
320
RoW
OCT-guided PCI, Angiography-guided PCI, Drug-eluting stent
Chonnam National University Hospital, Abbott Medical Devices
Coronary Artery Disease, Angina Pectoris
08/24
12/26
NCT05065125: Clinical Usefulness of Digital Single-operator Cholangioscopy(SpyGlassâ„¢) for Post-liver Transplant Anastomotic Stricture

Recruiting
N/A
40
RoW
digital single-operator cholangioscopy
Seoul National University Hospital
Liver Transplant; Complications, Biliary Duct Obstruction, Anastomosis, Obstructed
09/24
12/24
NCT06630455: Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia

Not yet recruiting
N/A
100
RoW
Meu-cinn, Placebo
Pusan National University Yangsan Hospital
Functioanl Dyspepsia
12/25
12/25
NCT05596370: Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer

Recruiting
N/A
150
RoW
cell free DNA in blood and urine, metabolite/microbiome in urine and stool
Seoul National University Hospital, DXOME CO., LTD.
Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer
12/24
12/24
DOSE, NCT05702060: Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA

Recruiting
N/A
1010
RoW
Radial Artery Puncture Method for Coronary Angiography and Intervention
Yonsei University, Myung In Pharm
Radiation Exposure
12/25
12/25
NCT05497271: Confirmation of Association Between Cystic Fluid Analysis With Pancreatic Cystic Lesions

Recruiting
N/A
500
RoW
Seoul National University Hospital
Pancreatic Cyst, Molecular, Chemical Analysis of Cystic Fluid
12/25
12/25
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Recruiting
N/A
2400
RoW
Percutaneous Coronary Intervention
Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd
Coronary Disease
12/26
07/30
DCB-HBR, NCT05221931: Drug-Coated Balloon in Patients With High Bleeding Risk

Recruiting
N/A
1350
RoW
Percutaneous coronary intervention
Samsung Medical Center, Seoul St. Mary's Hospital, Seoul National University Bundang Hospital, Korea University Ansan Hospital, Chonnam National University Hospital, Chung-Ang University Gwangmyeong Hospital, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gyeongsang National University Hospital, Uijeongbu St. Mary Hospital, Keimyung University Dongsan Medical Center, Inha University Hospital, Chungbuk National University, Wonju Severance Christian Hospital, SMG-SNU Boramae Medical Center, Kangbuk Samsung Hospital, Sungkyunkwan University, Ewha Womans University, Korea University Guro Hospital
Coronary Artery Disease
07/27
12/28
Symphony, NCT04912674: Evaluation of ™ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity

Recruiting
N/A
100
US
Symphony OCT System
International Spine Study Group Foundation, DePuy Synthes
Cervical Deformity
07/27
07/27
NCT06013306: Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study

Not yet recruiting
N/A
58
NA
Kang Stem Biotech Co., Ltd.
Knee Osteoarthritis
11/29
12/30
PCD 2, NCT04194996: Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0

Recruiting
N/A
200
US
Surgical intervention
International Spine Study Group Foundation, DePuy Synthes, Orthofix Inc.
Cervical Deformity
12/32
07/33
INCS/INAH, NCT05708157: Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis

Recruiting
N/A
240
RoW
concomitant intranasal antihistamine and corticosteroid
Gachon University Gil Medical Center, Hallym University Kangnam Sacred Heart Hospital, Gangneung Asan Hospital, Bundang Jesaeng Hospital, Chung-Ang University Gwangmyeong Hospital, Hallym University Medical Center
Allergic Rhinitis
02/24
02/24
NCT05604573: DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

Recruiting
N/A
150
RoW
cell free DNA in blood, genetic mutation in tissue
Seoul National University Hospital, GENECAST Co., Ltd.
Pancreatic Cancer
12/24
12/24
Hyung, Woo Jin
NCT02995850: A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

Completed
1/2
25
RoW
CRS+HIPEC
Yonsei University
Gastric Cancer With Peritoneal Metastasis (PCI<12)
04/22
05/22
NCT03385018: Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)

Recruiting
N/A
772
RoW
Radical total gastrectomy with D2 (D2 - #10) lymph node dissection by laparoscopic approach, Radical total gastrectomy with D2 (D2 - #10) lymph node dissection by open conventional approach
Yonsei University
Gastric Cancer
12/22
12/27
NCT01919242: Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study

Recruiting
N/A
10000
RoW
gastrectomy
Yonsei University
Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer
09/23
09/23
Koh, Yoon Woo
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Recruiting
N/A
2400
RoW
Percutaneous Coronary Intervention
Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd
Coronary Disease
12/26
07/30
Kim, Sang Woo
REMBRANDT, NCT04700436: Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

Recruiting
4
240
RoW
Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg), Suvast tablet 10 mg (Rosuvastatin 10 mg)
Seoul National University Hospital, Gangnam Severance Hospital
Endocrine System Diseases, Nutritional and Metabolic Diseases, Diabetes Mellitus, Type 2, Dyslipidemias
05/21
11/21
OPTIMIZE-APT, NCT05418556: Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Recruiting
4
3944
RoW
aspirin, clopidogrel, prasugrel, ticagrelor
Asan Medical Center
Coronary Artery Disease
08/27
12/28
NCT06493799: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Not yet recruiting
3
226
NA
LAENNEC (Human Placenta Hydrolysate) IV, LAENNEC (Human Placenta Hydrolysate) SC
Green Cross Wellbeing
Chronic Liver Disease
12/25
12/25
DESTINY, NCT05334368: Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

Recruiting
3
120
Europe, Canada, Japan, US, RoW
Depemokimab, Placebo
GlaxoSmithKline
Hypereosinophilic Syndrome
02/26
03/26
DEBULK, NCT05421650: Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Recruiting
3
234
RoW
CCRT, Surgical debulking of bulky or multiple lymph nodes
CHA University, Gachon University Gil Medical Center, Seoul St. Mary's Hospital, Korea University Ansan Hospital, National Cancer Center, Korea, Samsung Medical Center, Gangnam Severance Hospital, Asan Medical Center, Ewha Womans University, Hanyang University, DongGuk University, Seoul National University Hospital, Severance Hospital, Keimyung University Dongsan Medical Center, Kyungpook National University Chilgok Hospital, Pusan National University Yangsan Hospital, Korean Gynecologic Oncology Group
Cervical Cancer
03/26
03/29
SPRINTR, NCT05955924: Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

Recruiting
3
396
Canada
Nicotinamide, niacinamide, Placebo
Women's College Hospital, Canadian Institutes of Health Research (CIHR), University Health Network, Toronto, NOW Foods
Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell, Keratinocyte Carcinoma
08/27
08/27
NCT05819658: GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)

Completed
2
78
RoW
GV1001 Placebo, Normal saline, GV1001 0.56mg, Tertomotide 0.84mg, GV1001 1.12mg, Tertomotide 1.68mg
GemVax & Kael
Progressive Supranuclear Palsy
10/24
10/24
NCT06235775: Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Active, not recruiting
2
67
RoW
GV1001 Placebo, Normal saline, GV1001 1.12mg, Tertomotide 1.68mg
GemVax & Kael
Progressive Supranuclear Palsy
11/25
12/25
NCT06568042: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Recruiting
2
450
Europe, Canada, Japan, US, RoW
LY3848575, Placebo
Eli Lilly and Company
Neuropathic Pain, Distal Sensory Polyneuropathy
06/26
09/26
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects

Recruiting
2
240
US, RoW
HM15211, Placebo of HM15211
Hanmi Pharmaceutical Company Limited
NASH - Nonalcoholic Steatohepatitis
05/26
11/26
BT5528-100, NCT04180371 / 2019-003653-29: Study in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Recruiting
1/2
288
Europe, US, RoW
BT5528, Nivolumab, Opdivo
BicycleTx Limited
Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Head and Neck Cancer, Triple Negative Breast Cancer, Gastric/Upper Gastrointestinal Cancer
10/25
10/25
NCT05292950 / 2022-003467-21: Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

Terminated
1
78
Europe, RoW
ARO-MUC5AC, Placebo
Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.
Asthma, Chronic Obstructive Pulmonary Disease
11/24
11/24
NCT05276570 / 2022-003466-20: Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Active, not recruiting
1
275
Europe, RoW
ARO-RAGE, Placebo
Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.
Asthma
03/25
03/25
RELIF-C, NCT02865369: Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Not yet recruiting
N/A
103
RoW
Daclatasvir and Asunaprevir, Daclatasvir and Asunaprevir combined treatment for 24 weeks
Sang Gyune Kim, Seoul National University Boramae Hospital, Severance Hospital, Inha University Hospital, Korea University, Gachon University Gil Medical Center, Hanyang University Seoul Hospital, Ewha Womans University Mokdong Hospital, Bristol-Myers Squibb
Chronic Hepatitis C
12/18
12/22
NCT04554758: Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation

Recruiting
N/A
400
RoW
Sleeve gastrectomy, Roux-en-Y gastric bypass
Inha University Hospital, Korean Center for Disease Control and Prevention
Obesity, Morbid, Overnutrition, Nutrition Disorders, Overweight and Obesity, Body Weight Changes
08/22
08/23
KARAHOC, NCT05578573: Comparison Between Conventional Angiocatheter Versus New Anchoring Device () Used for Paracentesis

Enrolling by invitation
N/A
80
RoW
KARAHOC device, Angiocatheter
Sang Gyune Kim
Ascites Hepatic
12/22
12/22
NCT05354791: Pre-post Spinal Popliteal Block

Terminated
N/A
1500
US
Hospital for Special Surgery, New York
Foot Surgery, Ankle Surgery
03/23
03/23
NCT05435885: Effects of Comprehensive Postoperative Pulmonary Tele-Rehabilitation in Elderly Patients With Resectable Lung Cancer

Completed
N/A
96
RoW
Pulmonary Tele-Rehabilitation, Control (Education)
Pusan National University Hospital, National Research Foundation of Korea
Telerehabilitation, Carcinoma, Non-Small-Cell Lung, Cardiopulmonary Exercise Test
02/24
02/24
rTMS, NCT03720691: Treatment in Vascular Parkinsonism

Not yet recruiting
N/A
32
RoW
Real rTMS Supplementary motor area, Real repetitive transcranial magnetic stimulation, Sham rTMS Supplementary motor area, Sham repetitive transcranial magnetic stimulation
Inje University, Dongtan Sacred Heart Hospital
Vascular Parkinsonism
12/24
12/25
NCT05962086: Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism

Recruiting
N/A
1500
RoW
Seoul National University Hospital, Asan Medical Center, Severance Hospital, Samsung Medical Center, Keimyung University Dongsan Medical Center, Pusan National University Yangsan Hospital
Spinal Dysraphism
12/24
12/24
NCT04356612: Barriers to Efficient PACU Discharge At a Major Academic Orthopaedic Ambulatory Surgery Center

Active, not recruiting
N/A
1000
US
Chart Review
Hospital for Special Surgery, New York
Achilles Tendon Rupture, Database
11/25
11/25
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Recruiting
N/A
2400
RoW
Percutaneous Coronary Intervention
Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd
Coronary Disease
12/26
07/30
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Recruiting
N/A
4000
RoW
high-intensity statin arm, low-intensity statin plus ezetimibe
Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation
Pre Diabetes, ASCVD
12/27
12/27
Ahn, Sang Hoon
LONGHEAD, NCT03042520: Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Recruiting
N/A
200
RoW
Observation only
Kaohsiung Medical University Chung-Ho Memorial Hospital, Chang Gung Memorial Hospital, National Taiwan University Hospital, National Cheng-Kung University Hospital, Chi Mei Medical Hospital, China Medical University, China, Mackay Memorial Hospital, Taipei Veterans General Hospital, Taiwan, Changhua Christian Hospital, Pusan National University Hospital, Asan Medical Center, Korea University, Inje University, Korea University Guro Hospital, Kyungpook National University Hospital, Seoul National University Hospital, Severance Hospital, Samsung Medical Center, Seoul National University Bundang Hospital, Soon Chun Hyang University, Seoul St. Mary's Hospital, Gachon University Gil Medical Center, Dong-A University Hospital, Gangnam Severance Hospital
Liver Fibroses, HepatoCellular Carcinoma, Cryoglobulinemia, Metabolic Disease, Diabetes Mellitus
09/22
09/22
NCT04139850: The Establishment of Korean Hepatitis B Patients Cohort

Recruiting
N/A
2000
RoW
Discontinuation of antiviral treatment in chronic hepatitis B cohort patients
Yonsei University
Chronic Hepatitis B
08/26
08/26
Kim, Hyoung
NCT03396354: Prospective Comparison of Surgical Outcomes With Using Integrated Robotic Technology Versus Conventional Laparoscopy for Gastric Cancer Surgery

Recruiting
N/A
140
RoW
Integrated robotic surgery, Conventional laparoscopic surgery
Yonsei University
Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
12/23
12/23
Chang, Hyuk-Jae
NCT05939258: Data Acquisition for Connected Network for EMSs Comprehensive Technical-support Using Artificial Intelligence

Completed
N/A
15296
RoW
Yonsei University
Emergency Patients Being Transported by Rescue Ambulance
12/21
12/21
NCT04829279: Evaluation of Effectiveness for Connected Network for EMS Comprehensive Technical-support Using Artificial Intelligence (CONNECT-AI) System by Community Intervention

Completed
N/A
15392
RoW
CONNECT AI system group
Yonsei University
Emergency Patient Transported by Ambulance
12/21
12/21
 

Download Options